Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo E Mendes

Showing results (101-110 of 278) with videos related to

Pageof 28
Sort By:
Microbiology Spectrum|October 10, 2024
<i>In vitro</i> activity assessment of cefiderocol against Enterobacterales, <i>Pseudomonas aeruginosa,</i> and <i>Acinetobacter</i> spp., including β-lactam nonsusceptible molecularly characterized isolates, collected from 2020 to 2021 in the United States and European hospitalsJohn H Kimbrough, Joshua M Maher, Helio S Sader, et al.
Antibiotics (Basel, Switzerland)|April 29, 2025
Characterization of <i>Enterobacter cloacae</i> and <i>Citrobacter freundii</i> Species Complex Isolates with Decreased Susceptibility to Cephalosporins from United States Hospitals and Activity of Aztreonam-Avibactam and Comparator Agents (2019-2023)Helio S Sader, Timothy B Doyle, John H Kimbrough, et al.
Antibiotics (Basel, Switzerland)|June 27, 2024
Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and <i>Pseudomonas aeruginosa</i> from Intensive Care Unit and Non-Intensive Care Unit PatientsHelio S Sader, Rodrigo E Mendes, John H Kimbrough, et al.
Antimicrobial Agents and Chemotherapy|November 22, 2021
Activity of Oritavancin against Gram-Positive Pathogens Causing Bloodstream Infections in the United States over 10 Years: Focus on Drug-Resistant Enterococcal Subsets (2010-2019)Cecilia G Carvalhaes, Helio S Sader, Jennifer M Streit, et al.
Diagnostic Microbiology and Infectious Disease|October 21, 2021
Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020)Helio S Sader, Rodrigo E Mendes, Jennifer M Streit, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 2010
Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008)Mariana Castanheira, Amy A Watters, Rodrigo E Mendes, et al.
The Journal of Antimicrobial Chemotherapy|August 30, 2021
Increasing frequency of OXA-48-producing Enterobacterales worldwide and activity of ceftazidime/avibactam, meropenem/vaborbactam and comparators against these isolatesMariana Castanheira, Timothy B Doyle, Timothy D Collingsworth, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 29, 2025
Antimicrobial susceptibility of clinical isolates of Stenotrophomonas maltophilia from Europe, Asia, and Latin America (2018-2023)Helio S Sader, Rodrigo E Mendes, Timothy B Doyle, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2013
Prevalence of β-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010)Mariana Castanheira, Sarah E Farrell, Lalitagauri M Deshpande, et al.
Diagnostic Microbiology and Infectious Disease|January 21, 2014
Resistance surveillance program report for selected European nations (2011)Ronald N Jones, Mirela Flonta, Nazahat Gurler, et al.
Pageof 28

Showing results (101-110 of 278) with videos related to

Sort By:
Pageof 28
Microbiology Spectrum|October 10, 2024
<i>In vitro</i> activity assessment of cefiderocol against Enterobacterales, <i>Pseudomonas aeruginosa,</i> and <i>Acinetobacter</i> spp., including β-lactam nonsusceptible molecularly characterized isolates, collected from 2020 to 2021 in the United States and European hospitalsJohn H Kimbrough, Joshua M Maher, Helio S Sader, et al.
Antibiotics (Basel, Switzerland)|April 29, 2025
Characterization of <i>Enterobacter cloacae</i> and <i>Citrobacter freundii</i> Species Complex Isolates with Decreased Susceptibility to Cephalosporins from United States Hospitals and Activity of Aztreonam-Avibactam and Comparator Agents (2019-2023)Helio S Sader, Timothy B Doyle, John H Kimbrough, et al.
Antibiotics (Basel, Switzerland)|June 27, 2024
Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and <i>Pseudomonas aeruginosa</i> from Intensive Care Unit and Non-Intensive Care Unit PatientsHelio S Sader, Rodrigo E Mendes, John H Kimbrough, et al.
Antimicrobial Agents and Chemotherapy|November 22, 2021
Activity of Oritavancin against Gram-Positive Pathogens Causing Bloodstream Infections in the United States over 10 Years: Focus on Drug-Resistant Enterococcal Subsets (2010-2019)Cecilia G Carvalhaes, Helio S Sader, Jennifer M Streit, et al.
Diagnostic Microbiology and Infectious Disease|October 21, 2021
Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020)Helio S Sader, Rodrigo E Mendes, Jennifer M Streit, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 2010
Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008)Mariana Castanheira, Amy A Watters, Rodrigo E Mendes, et al.
The Journal of Antimicrobial Chemotherapy|August 30, 2021
Increasing frequency of OXA-48-producing Enterobacterales worldwide and activity of ceftazidime/avibactam, meropenem/vaborbactam and comparators against these isolatesMariana Castanheira, Timothy B Doyle, Timothy D Collingsworth, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 29, 2025
Antimicrobial susceptibility of clinical isolates of Stenotrophomonas maltophilia from Europe, Asia, and Latin America (2018-2023)Helio S Sader, Rodrigo E Mendes, Timothy B Doyle, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2013
Prevalence of β-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010)Mariana Castanheira, Sarah E Farrell, Lalitagauri M Deshpande, et al.
Diagnostic Microbiology and Infectious Disease|January 21, 2014
Resistance surveillance program report for selected European nations (2011)Ronald N Jones, Mirela Flonta, Nazahat Gurler, et al.
Pageof 28